z-logo
Premium
The major subtypes of human B‐cell lymphomas lack mutations in BCL‐2 family member BAD
Author(s) -
Schmitz Roland,
Thomas Roman K.,
Harttrampf Anne C.,
Wickenhauser Claudia,
Schultze Joachim L.,
Hansmann MartinLeo,
Wolf Jürgen,
Küppers Ralf
Publication year - 2006
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.22010
Subject(s) - lymphoma , chronic lymphocytic leukemia , b cell , biology , mantle cell lymphoma , cancer research , pathogenesis , gene , follicular lymphoma , bcl10 , leukemia , genetics , immunology , antibody
Members of the BCL‐2 gene family are well known for their role in the pathogenesis of B‐cell lymphomas in humans and in mouse models. A recent report that knockout mice deficient for the proapoptotic BCL‐2 family member gene BAD frequently develop B‐cell lymphomas prompted us to analyze a large collection of human B‐cell lymphomas for inactivating mutations in the BAD gene. All 3 exons of the BAD gene were amplified and directly sequenced. The 81 lymphomas analyzed included 16 cases of B‐cell chronic lymphocytic leukemia, 11 mantle‐cell lymphomas, 10 follicular lymphomas, 7 MALT lymphomas, 8 Burkitt's lymphoma cell lines, 3 cell lines of multiple myeloma, 15 cases and 4 cell lines of diffuse large B‐cell lymphoma and 7 Hodgkin's lymphoma lines. No mutations were found in any of the cases. We conclude that mutations in the BAD gene do not play a role in the pathogenesis of the major subtypes of human B‐cell lymphomas. © 2006 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom